Literature DB >> 29142061

Effects of regulatory BC1 RNA deletion on synaptic plasticity, learning, and memory.

Ain Chung1, Nessy Dahan2, Juan Marcos Alarcon3,2, André A Fenton1,3,4.   

Abstract

Nonprotein coding dendritic BC1 RNA regulates translation of mRNAs in neurons. We examined two lines of BC1 knockout mice and report that loss of BC1 RNA exaggerates group I mGluR-stimulated LTD of the Schaffer collateral synapse, with one of the lines showing a much more enhanced DHPG-induced LTD than the other. When the animals were given the hippocampus-synaptic plasticity-dependent active place avoidance task, learning and memory were impaired in the BC1-KO line with the more severely altered DHPG-induced LTD. These findings indicate a role for BC1 RNA control of mGluR-dependent synaptic function in hippocampus and associated cognitive ability.
© 2017 Chung et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29142061      PMCID: PMC5688958          DOI: 10.1101/lm.045617.117

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


Brain cytoplasmic (BC) RNAs are a nonprotein-coding subtype of small cytoplasmic RNAs. BC1 RNA (BC200 in human and nonhuman primates) localizes to synapto-dendritic domains in neurons and regulates protein synthesis by targeting the initiation phase of translation (Tiedge et al. 1991, 1993; Wang et al. 2002, 2005; Eom et al. 2011, 2014). BC1 RNA may contribute to maintaining translation homeostasis at synapses because it (1) represses translation stimulated by group I metabotropic glutamate receptor (mGluR) activation, and (2) group I mGluR-stimulated translation of synaptic proteins is exaggerated in the absence of BC1 RNA (Wang et al. 2002; Lin et al. 2008; Eom et al. 2014). In contrast to the substantial knowledge of the molecular actions of small cytoplasmic RNAs, relatively little is known about the role of BC RNAs in neural function and behavior. Here, using BC1 knockout (KO) mice, we investigated whether absence of BC1 RNA alters hippocampus group 1 mGluR-stimulated synaptic plasticity and hippocampus-dependent cognitive behavior. Two lines of BC1 KO mice were used; each derived from independent mutant ES cell lines. Each line initially had a mixed C57BL/6J and 129×1/SvJ background (Skryabin et al. 2003). The first “BC1 KO-13” line still has the mixed C57BL/6J and 129×1/SvJ background. The second, “BC1 KO-B” line, mostly has a C57BL/6J background, having been backcrossed over 15 generations. The corresponding WT-13 and WT-B wild-type (WT) mice were of the respective identical background. The mice were bred in house and were 8–12 wk old at the time of the physiological and behavioral assays. All procedures were carried out in accordance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals and were approved by the SUNY, Downstate Medical Center and the New York University Institutional Animal Care and Use Committees. To test whether the absence of BC1 RNA alters mGluR-stimulated hippocampus synaptic function, we investigated mGluR-stimulated long-term depression DHPG-induced LTD of CA3-to-CA1 Schaffer collateral synapses (Huber et al. 2001). Ex vivo electrophysiology was performed as described (Alarcon et al. 2004; Nicholls et al. 2008). Right dorsal transverse hippocampal slices (400 µm) were cut in ice-cold artificial cerebrospinal fluid (ACSF, in mM: NaCl 119, KCl 4, MgSO4 1.5, CaCl2 2.5, NaHCO3 26.2, NaH2PO4 1.0, and glucose 11, saturated with 95% O2, 5% CO2). Slices recovered at 36°C for 45 and 60 min at room temperature in ACSF and were then set in an interface recording chamber perfused with ACSF at 36°C. Field excitatory postsynaptic potentials (fEPSPs) from the CA1 “stratum radiatum” were evoked (pulse duration: 50 µs, pulse sampling: 0.017 Hz, pulse intensity: 40% of the maximum fEPSP slope) and detected using a pair of stimulation bipolar (FHC & Co) and recording borosilicate glass pipette (5–10 mΩ filled with ACSF; Sutter Instruments) electrodes. The group I mGluR agonist 3,5-dihydroxyphenylglycine (DHPG, 50 µM; Sigma-Aldrich) was used to induce DHPG-induced LTD (Huber et al. 2001). fEPSP responses were acquired using PClamp (Molecular Devices) and analyzed using Origin (Microcal Software). ANOVA with repeated measures, followed by the Holm–Šídák test for multiple comparisons were performed using Prism (GraphPad Software). Expression of DHPG-induced LTD was quantified as the reduction in fEPSP slope 40 min after DHPG treatment relative to the 15-min baseline prior to application of DHPG (Fig. 1). Because DHPG-induced LTD was indistinguishable for WT-13 mice and WT-B mice, they were combined into a single WT group. This was statistically justified because there were 5 mice per group and one-way ANOVA power analysis with three groups, α = 0.05 and β = 0.95, and the observed effect size 1.7 (η2 = 0.75), calls for group sizes of four. BC1 KO-B animals showed enhanced DHPG-induced LTD expression (65.18 ± 14.06%) compared with WT mice (86.45 ± 6.42%) and it was even larger in BC1 KO-13 mice (40.64 ± 10.20%). These observations were confirmed by a significant effect of genotype (F(2,23) = 29.96; P < 0.0001), and according to post hoc tests, the ranking of DHPG-induced LTD enhancement was BC1 KO-13 mice > BC1 KO-B mice > WT mice. These data indicate a role of BC1 RNA regulation of group I mGluR-dependent synaptic function, which is greater in BC1 KO-13 mice than BC1 KO-B mice.
Figure 1.

Absence of BC1 RNA exaggerates DHPG-induced LTD at the CA3–CA1 hippocampal synapse. (A) The graph shows the time course of CA3–CA1 synaptic responses during baseline recordings, induction of LTD by DHPG (50 µM for 20 min, solid gray line), and the washout period (40 min). DHPG-induced LTD is exaggerated in slices from BC1 KO-13 mice, in comparison with those from WT and BC1 KO-B mice. (B) Traces illustrate representative examples of evoked responses. At baseline, all groups showed similar fEPSP responses to the stimulation (a), but BC1 KO-13 animals showed the smallest slope of the fEPSP after DHPG application (b). Significant differences relative to WT mice at 40–55 min (for 15 min after 20 min of washout) are indicated by black asterisks, and relative to BC1 KO-B mice by gray asterisks (***) P < 0.0001. BC1 KO-13, n = 5; BC1 KO-B, n = 5; WT, n = 10.

Absence of BC1 RNA exaggerates DHPG-induced LTD at the CA3–CA1 hippocampal synapse. (A) The graph shows the time course of CA3–CA1 synaptic responses during baseline recordings, induction of LTD by DHPG (50 µM for 20 min, solid gray line), and the washout period (40 min). DHPG-induced LTD is exaggerated in slices from BC1 KO-13 mice, in comparison with those from WT and BC1 KO-B mice. (B) Traces illustrate representative examples of evoked responses. At baseline, all groups showed similar fEPSP responses to the stimulation (a), but BC1 KO-13 animals showed the smallest slope of the fEPSP after DHPG application (b). Significant differences relative to WT mice at 40–55 min (for 15 min after 20 min of washout) are indicated by black asterisks, and relative to BC1 KO-B mice by gray asterisks (***) P < 0.0001. BC1 KO-13, n = 5; BC1 KO-B, n = 5; WT, n = 10. Next we evaluated cognitive behavior in these two BC1 KO lines by testing them in the hippocampus synaptic plasticity-dependent active place avoidance paradigm (Cimadevilla et al. 2001; Pastalkova et al. 2006; Park et al. 2015). The place avoidance system consisted of a circular (40-cm diameter) rotating (1 rpm) arena located inside a behavioral room. PC-based video tracking (Tracker, Bio-Signal Group) triggered a constant current (60 Hz, 500 msec, 0.2 mA) footshock when the mouse entered a 60° shock zone for more than 500 msec, as described in Radwan et al. (2016). The shock repeated every 1.5 sec until the mouse exited the shock zone. Because the location of shock was fixed to the spatial cues that were placed around the room, effective place avoidance requires mice to use spatial information from the stationary distal room cues. On the first day of the behavioral protocol, the mice were habituated to the rotating arena for 30 min without shock. On the second day, each mouse received three 30-min training sessions with 2 h between sessions. On the third day, 24-h long-term memory retention was tested in identical conditions. Two hours later, two conflict training sessions were given with the shock sector relocated 180° from the original location, which was the preferred location during prior training. Indices of learning and memory were computed by TrackAnalysis software (Bio-Signal Group). BC1 KO and WT animals explored the rotating arena similarly during the pretraining session in which the shock was off (Fig. 2A). Locomotion was similar, measured by the total distance moved (F(2,17) = 0.68, P = 0.5), consistent with prior reports of no hyperactivity in BC1 KO mice (Lewejohann et al. 2004).
Figure 2.

Impaired spatial learning, memory, and cognitive flexibility in BC1 KO-13 animals in the active place avoidance task. (A) The panels show the tracking of a representative mouse for each group across the pretraining, training, 24-h retention test, and conflict training sessions. (B) BC1 KO-13 mice entered the shock zone (red sector in A) more often than BC1 KO-B or WT mice during the initial and conflict training sessions, suggesting a deficit in learning during training to avoid the initial shock zone location as well as during conflict training trials. (C) BC1 KO-13 mice were also impaired relative to the other two genotypes in the 24-h memory retention test, which was assessed by a shorter path walked before entering the shock zone for the first time. Significant differences relative to WT mice are indicated by black asterisks, and relative to BC1 KO-B mice by gray asterisks (*) P < 0.05, (**) P < 0.005, BC1 KO-13, n = 5; BC1 KO-B, n = 6; WT, n = 12.

Impaired spatial learning, memory, and cognitive flexibility in BC1 KO-13 animals in the active place avoidance task. (A) The panels show the tracking of a representative mouse for each group across the pretraining, training, 24-h retention test, and conflict training sessions. (B) BC1 KO-13 mice entered the shock zone (red sector in A) more often than BC1 KO-B or WT mice during the initial and conflict training sessions, suggesting a deficit in learning during training to avoid the initial shock zone location as well as during conflict training trials. (C) BC1 KO-13 mice were also impaired relative to the other two genotypes in the 24-h memory retention test, which was assessed by a shorter path walked before entering the shock zone for the first time. Significant differences relative to WT mice are indicated by black asterisks, and relative to BC1 KO-B mice by gray asterisks (*) P < 0.05, (**) P < 0.005, BC1 KO-13, n = 5; BC1 KO-B, n = 6; WT, n = 12. Place avoidance training began the next day with activation of the shock zone. Across the three training trials, all genotypes decreased the number of times they entered the shock zone, indicating place learning (Fig. 2B). The two WT groups were indistinguishable and so were combined, as in the DHPG-induced LTD study. This was statistically justified because the group sizes were 5 or 6 mice and two-way ANOVA power analysis with three groups, α = 0.05 and β = 0.95, and the observed interaction effect size = 0.60 (η2 = 0.26) calls for group sizes of four. The BC1 KO-13 mice were slower to learn the avoidance in comparison to the BC1 KO-B mice and WT mice, which did not appear to differ from each other. Indeed, the WT and BC1 KO-B mice also showed the typical across-trial increase in how far they were able to walk before first entering the shock zone on each trial, indicating they formed long-term place memory, whereas the BC1 KO-13 did not demonstrate a clear increase. Twenty-four hour memory retention also looked clearly impaired in BC1 KO-13 mice, assessed by the path-to-first-entrance measure but a learning deficit was not expressed on this 24-h retention trial. Relocating the shock zone for the conflict sessions initially caused all animals to increase the number of entries to the new shock zone, which they entered virtually immediately. Because the BC1 KO-13 mice were slowest to learn the initial shock zone and did not express strong memory retention, one might have expected them to have the least difficulty with the conflict, because their initial conditioned place response was presumably easier to suppress than the well-learned responses of the other groups. However, the BC1 KO-13 seemed to be more disturbed than the WT and BC1 KO-B mice. The mice appeared to subsequently learn to avoid the new shock zone because the number of entrances decreased across the two conflict sessions in all the genotypes, but long-term memory was not expressed in BC1 KO-13 mice as their path to the first entrance did not appear to increase, indicating impaired cognitive flexibility. These impressions were confirmed by two-way genotype × trial ANOVAs, with repeated measures on the factor trial. The effects of genotype (entrances: F(2,20) = 9.73, P < 0.005; path to first enter: F(2,20) = 3.55, P < 0.05) and trial (entrances: F(6,120) = 158.7, P < 0.0001; path to first enter: F(6,120) = 6.50, P < 0.0001) were significant for both the measure of learning (Fig. 2B) and the measure of long-term memory retention (Fig. 2C). The interaction was significant for the number of entrances (F(12,120) = 2.63, P < 0.005) but not for the path to the first entrance (F(12,120) = 1.26, P < 0.25). Post hoc tests confirmed no differences between WT and BC1 KO-B mice, and relative to these genotypes, the BC1 KO-13 mice were impaired on the initial learning and conflict trials (Fig. 2B). The BC1 KO-13 mice expressed impaired long-term memory relative to WT and BC1 KO-B mice on the 24-h retention and the two conflict trials once long-term memory was strongly expressed by the other genotypes (Fig. 2C). BC1 KO-13 mice express cognitive impairments in active place avoidance not observed in BC1 KO-B mice. While there is no evidence that DHPG-induced LTD abnormality causes the cognitive deficits, a larger abnormality in DHPG-induced LTD is observed in BC1 KO-13 mice, and we do not know what additional consequences the loss of BC1 RNA throughout the brain may have had (e.g., compensatory changes). The present findings demonstrate functional abnormality after loss of BC1 RNA by demonstrating, for the first time, synaptic plasticity changes and parallel impairment of behavior known to involve the altered synapses. Prior behavioral work contrasts with the present findings. In that work, BC1-mutant mice expressed impaired spontaneous exploratory behavior and higher anxiety-like behavior but no differences in learning or memory assessed by a test battery that included the Barnes, Water, Radial 8-Arm, Multiple-T, and alley mazes (Lewejohann et al. 2004). The task variant we used is no more stressful than exploration of a familiar space (Lesburgueres et al. 2017), and it is sensitive to inactivation of the basolateral amygdala, orbitofrontal, and retrosplenial cortices (Vafaei and Rashidy-Pour 2004; Vafaei et al. 2007; Wesierska et al. 2009). It may be one of the most sensitive tasks to dorsal hippocampal dysfunction because it is even impaired by unilateral hippocampal inactivation (Cimadevilla et al. 2001). Not only does the task require place learning and persistent hippocampus LTP-dependent memory persistence (Pastalkova et al. 2006; Park et al. 2015; Tsokas et al. 2016; Hsieh et al. 2017; Pavlowsky et al. 2017), but distinct from water maze place learning (Kubík and Fenton 2005), the active place avoidance task also requires cognitive control to segregate and prioritize information about stable locations over information about rotating locations (Bures et al. 1997; Wesierska et al. 2005; Kelemen and Fenton 2010). This cognitive control component may have been critical to detecting the deficits because impaired cognitive control, assessed in an odor discrimination attentional set-shifting task was also recently reported in these BC1 KO strains (Iacoangeli et al. 2017). Absence of BC1 RNA resulted in exaggerated DHPG-induced LTD. This follows because dendritically transported BC1 RNA interacts with the translation initiation machinery by binding to eukaryotic initiation factors eIF4A (an RNA helicase) and eIF4B (a modulator of eIF4A function), thereby blocking the recruitment and formation of 48S initiation complexes (Wang et al. 2002; Lin et al. 2008; Eom et al. 2014). While we did not experimentally block translation in the present studies, anisomycin was used in prior investigations of BC1-mutant mice that confirmed BC1 RNA represses translation downstream from MEK–ERK signaling in a sequential-independent manner to the fragile X mental retardation protein (FMRP) (Zhong et al. 2010). Consequently, BC1 RNA absence results in hippocampal CA3 hyperexcitability following group I mGluR stimulation and audiogenic seizures, both of which are blocked by pretreatment with anisomycin (Zhong et al. 2009), and are further exaggerated when FMRP is also absent (Zhong et al. 2010). While it is beyond the present scope to determine whether other forms of synaptic function and plasticity are also altered, diverse abnormalities are predicted given the broad expression of BC1 RNA and its role in repressing translation. The present findings add to prior reports of increased synthesis of synaptic proteins (Cheng et al. 1996), increased prolonged CA3 epileptiform discharges, increased susceptibility to audiogenic seizures, and excessive cortical γ oscillations in the absence of BC1 RNA, all of which are triggered by group 1 mGluR stimulation (Zhong et al. 2009, 2010; Iacoangeli and Tiedge 2013). Given that BC1 RNA and FMRP both repress translation, albeit by different mechanisms, it is noteworthy that all of these abnormalities have also been observed in Fmr1 KO mice that lack FMRP to model the FXS genetic defect (Huber et al. 2001; Chuang et al. 2005; Zhong et al. 2010; Bhakar et al. 2012; Gonçalves et al. 2013; Radwan et al. 2016). Causal relationships remain to be confirmed among these abnormalities that span the molecular, cellular, network, and behavioral levels of biological organization. The two BC1 KO strains differed in the severity of the abnormalities that we measured. Prior work with the BC1 KO-B mice showed a mild active place avoidance deficit (Zhong et al. 2010), using a harder to learn protocol of three 10-min sessions per day for 3 d (Tsokas et al. 2016), however, the deficit was not as severe as we observed in the BC1 KO-13 strain. It is well documented that both physiology and behavior can be impacted by the background strain of a mouse (Yoshiki and Moriwaki 2006; Spencer et al. 2011; Darnell 2014; Ishimura et al. 2014; Lei et al. 2014). Phenotypic differences including fear-learning deficits due to Fmr1 deletion are weaker in C57Bl/6 mice compared with the 129×1/SvJ strain (Paradee et al. 1999; Moy et al. 2009; Spencer et al. 2011). The strain differences we observed could arise because BC1 RNA translational control is extraordinary in the C57Bl/6J strain compared with other strains (Darnell 2014; Ishimura et al. 2014), and thus less severe phenotypic consequences of BC1 RNA absence could manifest in the BC1 KO-B line. Known complex molecular interactions may also play a role. Specifically, BC1 RNA binds to FMRP to increase the protein's mRNA target specificity (Zalfa et al. 2003). In addition, FMRP expression is higher in the absence of BC1 RNA, measured with both background strains (Zhong et al. 2009). Thus the differences we detected in the phenotypic expression of the two BC1 KO strains highlight the potential importance of genetic background. In the present case, there is both the possibility of background-strain dependent partial compensation for loss of BC1-mediated translation repression by FMRP as well as exaggerated FMRP loss of function in the absence of BC1 RNA (Zalfa et al. 2003; Zhong et al. 2009). In addition, the differences may also result from the nonlinear relationships between deficits in molecular signaling, physiological, and behavioral consequences, a fact that presents a major challenge to understanding how molecular mechanisms of disease and dysfunction cause clinical symptoms (Mitchell et al. 2013). The present findings add to the evidence that translation regulation in neurons, including by nonprotein coding RNA, is a mechanism of complex neural circuit and brain function, the disruption of which is sufficient to result in synaptic plasticity and cognitive dysfunction (Darnell et al. 2011).
  44 in total

1.  Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

Authors:  K M Huber; J C Roder; M F Bear
Journal:  J Neurophysiol       Date:  2001-07       Impact factor: 2.714

2.  Dual nature of translational control by regulatory BC RNAs.

Authors:  Taesun Eom; Valerio Berardi; Jun Zhong; Gianfranco Risuleo; Henri Tiedge
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

3.  Molecular biology. Ribosome rescue and neurodegeneration.

Authors:  Jennifer C Darnell
Journal:  Science       Date:  2014-07-24       Impact factor: 47.728

4.  Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function.

Authors:  W Paradee; H E Melikian; D L Rasmussen; A Kenneson; P J Conn; S T Warren
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility.

Authors:  Russell E Nicholls; Juan Marcos Alarcon; Gaël Malleret; Reed C Carroll; Michael Grody; Svetlana Vronskaya; Eric R Kandel
Journal:  Neuron       Date:  2008-04-10       Impact factor: 17.173

6.  BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability.

Authors:  Jun Zhong; Shih-Chieh Chuang; Riccardo Bianchi; Wangfa Zhao; Heekyung Lee; André A Fenton; Robert K S Wong; Henri Tiedge
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

7.  FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

Authors:  Jennifer C Darnell; Sarah J Van Driesche; Chaolin Zhang; Ka Ying Sharon Hung; Aldo Mele; Claire E Fraser; Elizabeth F Stone; Cynthia Chen; John J Fak; Sung Wook Chi; Donny D Licatalosi; Joel D Richter; Robert B Darnell
Journal:  Cell       Date:  2011-07-22       Impact factor: 41.582

8.  Motor and cognitive deficits in aged tau knockout mice in two background strains.

Authors:  Peng Lei; Scott Ayton; Steve Moon; Qihao Zhang; Irene Volitakis; David I Finkelstein; Ashley I Bush
Journal:  Mol Neurodegener       Date:  2014-08-14       Impact factor: 14.195

9.  Regulatory BC1 RNA in cognitive control.

Authors:  Anna Iacoangeli; Aderemi Dosunmu; Taesun Eom; Dimitre G Stefanov; Henri Tiedge
Journal:  Learn Mem       Date:  2017-06-15       Impact factor: 2.460

10.  Circuit level defects in the developing neocortex of Fragile X mice.

Authors:  J Tiago Gonçalves; James E Anstey; Peyman Golshani; Carlos Portera-Cailliau
Journal:  Nat Neurosci       Date:  2013-06-02       Impact factor: 24.884

View more
  4 in total

1.  Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.

Authors:  Ilham A Muslimov; Anna Iacoangeli; Taesun Eom; Anne Ruiz; Madisen Lee; Stacy Stephenson; Ellen M Ginzler; Henri Tiedge
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

2.  A multi-omics longitudinal study of the murine retinal response to chronic low-dose irradiation and simulated microgravity.

Authors:  Prachi Kothiyal; Greg Eley; Hari Ilangovan; Katherine A Hoadley; S Robin Elgart; Xiao W Mao; Parastou Eslami
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

Review 3.  On the functional relevance of spatiotemporally-specific patterns of experience-dependent long noncoding RNA expression in the brain.

Authors:  Wei-Siang Liau; Sarbani Samaddar; Sourav Banerjee; Timothy W Bredy
Journal:  RNA Biol       Date:  2021-01-04       Impact factor: 4.652

4.  BC RNA Mislocalization in the Fragile X Premutation.

Authors:  Ilham A Muslimov; Taesun Eom; Anna Iacoangeli; Shih-Chieh Chuang; Renate K Hukema; Rob Willemsen; Dimitre G Stefanov; Robert K S Wong; Henri Tiedge
Journal:  eNeuro       Date:  2018-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.